Literature DB >> 19101201

Combined cardiac sympathetic excitation and vagal impairment in patients with non-organic erectile dysfunction.

Chih J Chen1, Terry B J Kuo, Yi-Jhan Tseng, Cheryl C H Yang.   

Abstract

OBJECTIVE: Patients with non-organic erectile dysfunction (ED) frequently present with syndromes involving systemic sympathovagal dysfunction. The linkage of ED to cardiac autonomic regulation is not well understood.
METHODS: Forty-four men with non-organic ED and 38 healthy age-matched control subjects with ages ranging from 40 years to 69 years were recruited. These two groups were divided into three distinct age categories at 10-year intervals. Patients were divided into three different severity categories, among whom 35 patients received a two-month oral treatment of trazodone. Power spectral analysis of successive R-R intervals (RR) was performed to evaluate the variance (variance of RR-interval values), the high-frequency power (HF), and the ratio of low-frequency power to HF (LF/HF) of their heart rate variability (HRV).
RESULTS: Patients exhibited a significantly lower variance and HF, but a higher LF/HF compared to the control group across all age categories. The changes in variance and HF were severity dependent. In addition, all the HRV parameters of the patients with a satisfactory response after treatment have significantly improved.
CONCLUSION: The results indicate that patients with non-organic ED had significant cardiac sympathetic hyperactivity and severity-dependent cardiac vagal impairment. SIGNIFICANCE: Non-organic ED may be accompanied by an abnormality in cardiac autonomic regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101201     DOI: 10.1016/j.clinph.2008.10.155

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  20 in total

Review 1.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

3.  The relationship between resting heart rate variability and erectile tumescence among men with normal erectile function.

Authors:  Christopher B Harte
Journal:  J Sex Med       Date:  2013-06-26       Impact factor: 3.802

4.  Effects of far-infrared radiation on heart rate variability and central manifestations in healthy subjects: a resting-fMRI study.

Authors:  Yii-Jeng Lin; Yen-Ying Kung; Wen-Jui Kuo; David M Niddam; Chou-Ming Cheng; Chih-Che Chou; Tzu-Chen Yeh; Jen-Chuen Hsieh; Jen-Hwey Chiu
Journal:  Lasers Med Sci       Date:  2014-09-24       Impact factor: 3.161

5.  Heart Rate Variability and Erectile Function in Younger Men: A Pilot Study.

Authors:  Rui Miguel Costa; Paula Mangia; José Pestana; David Costa
Journal:  Appl Psychophysiol Biofeedback       Date:  2021-01-02

6.  Inattentive and hyperactive preschool-age boys have lower sympathetic and higher parasympathetic activity.

Authors:  Tzong-Shi Wang; Wei-Lieh Huang; Terry B J Kuo; Guo-She Lee; Cheryl C H Yang
Journal:  J Physiol Sci       Date:  2012-10-18       Impact factor: 2.781

7.  Nicotine acutely inhibits erectile tumescence by altering heart rate variability.

Authors:  Christopher B Harte
Journal:  Urology       Date:  2014-03-15       Impact factor: 2.649

8.  Heart Rate Variability in Men with Erectile dysfunction.

Authors:  Ji Yong Lee; Kwan-Joong Joo; Jin Tae Kim; Sung Tae Cho; Dae Sung Cho; Yong-Yeun Won; Jong Bo Choi
Journal:  Int Neurourol J       Date:  2011-06-30       Impact factor: 2.835

9.  Association between cigarette smoking and erectile tumescence: the mediating role of heart rate variability.

Authors:  C B Harte; C M Meston
Journal:  Int J Impot Res       Date:  2013-01-10       Impact factor: 2.896

10.  Link between Peripheral Artery Disease and Heart Rate Variability in Hemodialysis Patients.

Authors:  Szu-Chia Chen; Chien-Fu Chen; Jiun-Chi Huang; Mei-Yueh Lee; Jui-Hsin Chen; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.